Hematology & Oncology Doctors in Georgetown, SC Accepting Medicare

4 Hematology & Oncology doctors found. Showing 1 - 4

Carol Ann Bogdan, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2405 N Fraser St, Georgetown, SC 29440 Phone: 843-545-7274    Fax: 843-545-8315

Dr. David Lee Milling, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2405 N Fraser St, Georgetown, SC 29440 Phone: 843-545-7274    Fax: 843-545-8315

Gretchen A Meyer, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2405 N Fraser St, Georgetown, SC 29440 Phone: 843-652-3600    Fax: 843-881-5012

Jeffrey William Cronk, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2405 N Fraser St, Georgetown, SC 29440 Phone: 843-652-3600    Fax: 925-778-3567

News Archive

Physical activity may reduce mortality risk among cognitively frail individuals

Cognitive frailty is a heterogeneous clinical manifestation characterized by the simultaneous presence of both physical frailty and cognitive impairment, in the absence of dementia, and it seems to entail a greater death risk than physical frailty or cognitive impairment separately.

Invacare sells ISG medical supplies business to AssuraMed

Invacare Corporation announced today that it has completed the sale of its Invacare Supply Group (ISG) medical supplies business to AssuraMed of Twinsburg, Ohio, a leader in wholesale and home-delivered medical supplies across the United States, for a purchase price of approximately $150.8 million in cash, which is subject to final post-closing adjustments.

Scientists take aim at virulent bacteria by decoding machinery of key control enzyme

By deciphering the ingenious mechanism used by a particular enzyme to modify bacterial chromosome chemistry, scientists have come a step closer to designing a new kind of drug that could stop virulent bacterial infections in their tracks. Their research will be published in the May 6 issue of the journal Cell.

EpiCept signs definitive agreements for purchase of 6.1M shares of common stock

EpiCept Corporation announced today that it entered into definitive agreements for the purchase of approximately 6.1 million shares of its common stock at $1.10 per share, five year warrants to purchase up to approximately 4.6 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010 and one year warrants to purchase up to approximately 6.1 million shares of common stock at an exercise price of $1.57 per share exercisable beginning December 30, 2010.

Read more Medical News

› Verified 8 days ago